Hi-Clearance Inc. (TPEX:1788)
Taiwan · Delayed Price · Currency is TWD 136.50
+0.50 (0.37%)
Feb 11, 2026, 1:30 PM CST
Hi-Clearance Revenue
Hi-Clearance had revenue of 1.07B TWD in the quarter ending September 30, 2025, with 5.62% growth. This brings the company's revenue in the last twelve months to 4.19B, up 3.34% year-over-year. In the year 2024, Hi-Clearance had annual revenue of 4.07B with 4.54% growth.
Revenue (ttm)
4.19B
Revenue Growth
+3.34%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.07B | 177.03M | 4.54% |
| Dec 31, 2023 | 3.90B | -793.91M | -16.93% |
| Dec 31, 2022 | 4.69B | 1.01B | 27.30% |
| Dec 31, 2021 | 3.68B | 252.04M | 7.34% |
| Dec 31, 2020 | 3.43B | 191.25M | 5.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 5.46B |
| TaiDoc Technology | 4.34B |
| InnoCare Optoelectronics | 2.18B |
| Dynamic Medical Technologies | 1.43B |
| WeLeader Biomedical | 1.06B |
| A Plus Biotechnology | 825.52M |
| Delta Asia International | 711.19M |
| Diamond Biotechnology | 698.11M |